SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
01 2Swati Spentose Private Limited
02 1Moehs BCN SL
03 1Moehs Catalana SL
04 1Supriya Lifescience Limited
05 1Apex Healthcare Limited
06 1AX Pharmaceutical Corp
07 1Asclemed USA Inc.
08 1Asclemed USA, Inc.
09 1Cambrex Karlskoga AB
10 1Delta Synthetic Co. Ltd
11 1Fagron Inc
12 1HETERO LABS LIMITED
13 1Harman Finochem Limited
14 1Isomedix Operations, Inc
15 1Kalchem International inc
16 1LETCO MEDICAL, LLC
17 1Medisca Inc.
18 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
19 2Professional Compounding Centers of America
20 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
21 2Spectrum Laboratory Products, Inc.
22 1Unilab Chemicals and Pharmaceuticals Private Limited
23 1Village Pharma LLC
24 1W. R. GRACE & CO.-CONN.
25 1Xenex Laboratories Inc
01 1LIDOCAINE
02 1LIDOCAINE HCL
03 1LIDOCAINE HCL MONOHYDRATE
04 3LIDOCAINE HYDROCHLORIDE
05 2Lidocaine
06 4Lidocaine HCl
07 14Lidocaine Hydrochloride
08 1Lidocaine hydrochloride
09 1lidocaine hydrochloride monohydrate
01 2Canada
02 7India
03 1Italy
04 1Latvia
05 1Netherlands
06 2Spain
07 1Taiwan
08 10U.S.A
09 3United Kingdom
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
NDC Package Code : 52119-002
Start Marketing Date : 2012-08-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0701
Start Marketing Date : 2009-09-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-2000
Start Marketing Date : 2011-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Apex Healthcare Limited: ISO 9001:2008, WHO-GMP, US FDA-audited manufacturer & exporter of APIs, bulk drugs, and formulations.
NDC Package Code : 69617-010
Start Marketing Date : 2019-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
NDC Package Code : 52119-009
Start Marketing Date : 2014-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 71495-0001
Start Marketing Date : 2017-05-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12651-113
Start Marketing Date : 2006-06-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22568-1082
Start Marketing Date : 2006-10-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12660-0321
Start Marketing Date : 1979-02-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 25119-5000
Start Marketing Date : 2021-05-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
14
PharmaCompass offers a list of Lidocaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lidocaine Hydrochloride manufacturer or Lidocaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lidocaine Hydrochloride manufacturer or Lidocaine Hydrochloride supplier.
A Astrazeneca Brand of Lidocaine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Astrazeneca Brand of Lidocaine, including repackagers and relabelers. The FDA regulates Astrazeneca Brand of Lidocaine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Astrazeneca Brand of Lidocaine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Astrazeneca Brand of Lidocaine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Astrazeneca Brand of Lidocaine supplier is an individual or a company that provides Astrazeneca Brand of Lidocaine active pharmaceutical ingredient (API) or Astrazeneca Brand of Lidocaine finished formulations upon request. The Astrazeneca Brand of Lidocaine suppliers may include Astrazeneca Brand of Lidocaine API manufacturers, exporters, distributors and traders.
click here to find a list of Astrazeneca Brand of Lidocaine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Astrazeneca Brand of Lidocaine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Astrazeneca Brand of Lidocaine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Astrazeneca Brand of Lidocaine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Astrazeneca Brand of Lidocaine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Astrazeneca Brand of Lidocaine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Astrazeneca Brand of Lidocaine suppliers with NDC on PharmaCompass.
We have 22 companies offering Astrazeneca Brand of Lidocaine
Get in contact with the supplier of your choice:
